Advertisement

Cognitive Outcome of Malaria and HIV Infection in Children in Sub-Saharan Africa

Abstract

Infections of the Central Nervous System (CNS) are a public health burden for children in sub-Saharan Africa. In addition to their high mortality, they are a major cause of both major and subtle cognitive deficits in children. With the advent of more effective treatments, there is increased survival of these children meaning that more children who have suffered CNS infections are surviving into adulthood with consequent short or long term cognitive deficits. This chapter reviews the current literature on the cognitive deficits resulting from CNS malaria and HIV infection, the main causes of cognitive deficits in African children among the infectious diseases. It also looks at the factors associated with these cognitive deficits and reviews different interventions to prevent or improve outcome.

Keywords

Central nervous system Malaria HIV/AIDS Infection Cognitive deficits Rehabilitation 

References

  1. 1.
    Al Serouri AW, Grantham-McGregor SM, Greenwood B, Costello A. Impact of asymptomatic malaria parasitaemia on cognitive function and school achievement of schoolchildren in the Yemen Republic. Parasitology. 2000;121(4):337–45.CrossRefGoogle Scholar
  2. 2.
    Bagenda D, Nassali A, Kalyesubula I, Sherman B, Drotar D, Boivin MJ, Olness K. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics. 2006;117(3):729–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Bangirana P, Giordani B, John CC, Page C, Opoka RO, Boivin MJ. Immediate neuropsychological and behavioral benefits of computerized cognitive rehabilitation in Ugandan pediatric cerebral malaria survivors. J Dev Behav Pediatr. 2009;30(4):310–8.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Bangirana P, John CC, Idro R, Opoka RO, Byarugaba J, Jurek AM, Boivin MJ. Socioeconomic predictors of cognition in Ugandan children: implications for community interventions. PLoS One. 2009;4(11):e7898.CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.
    Bangirana P, Allebeck P, Boivin MJ, John CC, Page C, Ehnvall A, Musisi S. Cognition, behaviour and academic skills after cognitive rehabilitation in Ugandan children surviving severe malaria: a randomised trial. BMC Neurol. 2011;11(1):96.CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Bangirana P, Opoka RO, Boivin MJ, Idro R, Hodges JS, Romero RA, Shapiro E, John CC. Severe malarial anemia is associated with long-term neurocognitive impairment. Clin Infect Dis. 2014. doi: 10.1093/cid/ciu293. Oxford University Press.Google Scholar
  7. 7.
    Birbeck GL, Beare N, Lewallen S, Glover SJ, Molyneux ME, Kaplan PW, Taylor TE. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am J Trop Med Hyg. 2010;82(2):231–4.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Birbeck GL, Molyneux ME, Kaplan PW, Seydel KB, Chimalizeni YF, Kawaza K, Taylor TE. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol. 2010;9(12):1173–81.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Boivin MJ. Effects of early cerebral malaria on cognitive ability in Senegalese children. J Dev Behav Pediatr. 2002;23(5):353–64.CrossRefPubMedGoogle Scholar
  10. 10.
    Boivin MJ, Green SD, Davies AG, Giordani B, Mokili JK, Cutting WA. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol. 1995;14(1):13–21.CrossRefPubMedGoogle Scholar
  11. 11.
    Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, John CC. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119(2):e360–6.CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Boivin MJ, Busman RA, Parikh SM, Bangirana P, Page CF, Opoka RO, Giordani B. A pilot study of the neuropsychological benefits of computerized cognitive rehabilitation in Ugandan children with HIV. Neuropsychology. 2010;24(5):667–73. US: American Psychological Association.CrossRefPubMedGoogle Scholar
  13. 13.
    Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, et al. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS. 2010;24(8):1163–70.CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Boivin MJ, Gladstone MJ, Vokhiwa M, Birbeck GL, Magen JG, Page C, Semrud Clikeman M, Kauye F, Taylor TE. Developmental outcomes in Malawian children with retinopathy positive cerebral malaria. Trop Med Int Health. 2011;16(3):263–71. Wiley Online Library.CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Boivin MJ, Bangirana P, Nakasujja N, Page CF, Shohet C, Givon D, Bass JK, Opoka RO, Klein PS. A year-long caregiver training program improves cognition in preschool Ugandan children with human immunodeficiency virus. J Pediatr. 2013;163(5):1409–16. Elsevier.CrossRefGoogle Scholar
  16. 16.
    Carter JA, Ross AJ, Neville BG, Obiero E, Katana K, Mung’ala-Odera V, Lees JA, Newton CR. Developmental impairments following severe falciparum malaria in children. Trop Med Int Health. 2005;10(1):3–10. doi: 10.1111/j.1365-3156.2004.01345.x. TMI1345 [pii].CrossRefPubMedGoogle Scholar
  17. 17.
    Carter JA, Lees JA, Gona JK, Murira G, Rimba K, Neville B G, Newton C R. Severe falciparum malaria and acquired childhood language disorder. Dev Med Child Neurol. 2006;48(1):51–57. S0012162206000107 [pii] doi: 10.1017/S0012162206000107. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16359594
  18. 18.
    Clarke SE, Jukes MC, Njagi JK, Khasakhala L, Cundill B, Otido J, Crudder C, Estambale BB, Brooker S. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9633):127–38. S0140-6736(08)61034-X [pii] doi: 10.1016/S0140-6736(08)61034-X. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18620950
  19. 19.
    De Mast Q, Van Dongen-Lases EC, Swinkels DW, Nieman A-E, Roestenberg M, Druilhe P, Arens TA. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol. 2009;145(5):657–64. doi: 10.1111/j.1365-2141.2009.07664.x. Blackwell Publishing Ltd.CrossRefPubMedGoogle Scholar
  20. 20.
    Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647–57. Elsevier.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Drotar D, Olness K, Wiznitzer M, Guay L, Marum L, Svilar G, Hom D, Fagan JF, Ndugwa C, Kiziri-Mayengo R. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics. 1997. 100(1):E5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9200379
  22. 22.
    Dugbartey AT, Spellacy FJ, Dugbartey MT. Somatosensory discrimination deficits following pediatric cerebral malaria. Am J Trop Med Hyg. 1998. 59(3):393–96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9749631
  23. 23.
    Eggert D, Anderson E, Zheng JL, Gendelman HE, Goodkin K, Shapshak P, Verma A. Chemokines and the neuropathogenesis of HIV-1 infection. The spectrum of neuro-AIDS disorders: pathophysiology, diagnosis, and treatment. 2009:151–71. ASM Press, Washington DC.Google Scholar
  24. 24.
    Fernando D, de Silva D, Wickremasinghe R. Short-term impact of an acute attack of malaria on the cognitive performance of schoolchildren living in a malaria-endemic area of Sri Lanka. Trans R Soc Trop Med Hyg. 2003;97(6):633–9. S0035-9203(03)80093-7 [pii].CrossRefPubMedGoogle Scholar
  25. 25.
    Fernando D, Wickremasinghe R, Mendis KN, Wickremasinghe AR. Cognitive performance at school entry of children living in malaria-endemic areas of Sri Lanka. Trans R Soc Trop Med Hyg. 2003;97(2):161–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Fernando SD, Gunawardena DM, Bandara MR, De Silva D, Carter R, Mendis KN, Wickremasinghe AR. The impact of repeated malaria attacks on the school performance of children. Am J Trop Med Hyg. 2003;69(6):582–8.PubMedGoogle Scholar
  27. 27.
    Geiger C, Agustar HK, Compaore G, Coulibaly B, Sie A, Becher H, Lanzer M, Janisch T. Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in North-Western Burkina Faso between 2000 and 2009–2012. Malaria J. 2013;12(1):27. http://www.malariajournal.com/content/12/1/27
  28. 28.
    González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1):69–81. Nature Publishing Group.CrossRefPubMedGoogle Scholar
  29. 29.
    Halliday KE, Karanja P, Turner EL, Okello G, Njagi K, Dubeck MM, Allen E, Jukes MCH, Brooker SJ. Plasmodium falciparum, anaemia and cognitive and educational performance among school children in an area of moderate malaria transmission: baseline results of a cluster randomized trial on the coast of Kenya. Trop Med Int Health. 2012;17(5). Blackwell Publishing Ltd:532–49. doi: 10.1111/j.1365-3156.2012.02971.x.
  30. 30.
    Hoare J, Fouche J-P, Spottiswoode B, Donald K, Philipps N, Bezuidenhout H, Christine M, Webster V, Oduro C, Schrieff L. A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-Naïve ‘slow progressors’. J Neurovirol. 2012;18(3):205–12. Springer.CrossRefPubMedGoogle Scholar
  31. 31.
    Holding PA, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg. 1999;93(5):529–34.CrossRefPubMedGoogle Scholar
  32. 32.
    Idro R, Karamagi C, Tumwine J. Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda. Ann Trop Paediatr. 2004;24(1):17–24. doi: 10.1179/027249304225013240. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15005962
  33. 33.
    Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4(12):827–40. S1474-4422(05)70247-7 [pii] doi: 10.1016/S1474-4422(05)70247-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16297841
  34. 34.
    Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010;68(4):267–74. doi: 10.1203/PDR.0b013e3181eee738.CrossRefPubMedCentralPubMedGoogle Scholar
  35. 35.
    Jeremy RJ, Kim S, Nozyce M, Nachman S, McIntosh K, Pelton SI, Yogev R, et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics. 2005;115(2):380–87. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15687448
  36. 36.
    John CC, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, Wu B, Boivin MJ. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics. 2008;122(1):e92–9. doi: 10.1542/peds.2007-3709. peds.2007-3709 [pii].CrossRefPubMedCentralPubMedGoogle Scholar
  37. 37.
    John CC, Panoskaltsis-Mortari A, Opoka RO, Park GS, Orchard PJ, Jurek AM, Idro R, Byarugaba J, Boivin MJ. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg. 2008;78(2):198–205. 78/2/198 [pii].PubMedCentralPubMedGoogle Scholar
  38. 38.
    John CC, Kutamba E, Mugarura K, Opoka RO. Adjunctive therapy for cerebral malaria and other severe forms of plasmodium falciparum malaria. Expert Rev Anti Infect Ther. 2010;8(9):997–1008. doi: 10.1586/eri.10.90.CrossRefPubMedCentralPubMedGoogle Scholar
  39. 39.
    Jukes MC, Pinder M, Grigorenko EL, Smith HB, Walraven G, Bariau EM, Sternberg RJ, et al. Long-term impact of malaria chemoprophylaxis on cognitive abilities and educational attainment: follow-up of a controlled trial. PLoS Clin Trials. 2006;1(4):e19. doi: 10.1371/journal.pctr.0010019. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17013430
  40. 40.
    Kihara M, Carter JA, Newton CR. The effect of plasmodium falciparum on cognition: a systematic review. Trop Med Int Health. 2006;11(4):386–97. doi: 10.1111/j.1365-3156.2006.01579.x. TMI1579 [pii].CrossRefPubMedGoogle Scholar
  41. 41.
    Kihara M, Carter JA, Holding PA, Vargha-Khadem F, Scott RC, Idro R, Fegan GW, de Haan M, Neville BG, Newton CR. Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage. Malar J. 2009;8:273. doi: 10.1186/1475-2875-8-273. 1475-2875-8-273 [pii].CrossRefPubMedCentralPubMedGoogle Scholar
  42. 42.
    Kihara M, de Haan M, Garrashi HH, Neville BG, Newton CR. Atypical brain response to novelty in rural African children with a history of severe falciparum malaria. J Neurol Sci. 2010;296(1–2):88–95. S0022-510X(10)00219-4 [pii] doi: 10.1016/j.jns.2010.05.018. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20566207
  43. 43.
    Kimbi HK, Nformi D, Ndamukong KJ. Prevalence of asymptomatic malaria among school children in an urban and rural area in the Mount Cameroon region. Cent Afr J Med. 2005;51(1–2):5.PubMedGoogle Scholar
  44. 44.
    Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlstrom K, Gillberg CG, Forssberg H, Westerberg H. Computerized training of working memory in children with ADHD – a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2005;44(2):177–86. S0890-8567(09)61427-1 [pii]. doi: 10.1097/00004583-200502000-00010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15689731
  45. 45.
    Laughton B, Cornell M, Grove D, Kidd M, Springer PE, Dobbels E, van Rensburg AJ, Violari A, Babiker AG, Madhi SA. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 2012;26(13):1685–90. LWW.CrossRefPubMedCentralPubMedGoogle Scholar
  46. 46.
    Lozoff, B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr. 2011;141(4):740S–746S. doi: 10.3945/jn.110.131169. http://jn.nutrition.org/content/141/4/740S.abstract
  47. 47.
    McGrath N, Fawzi WW, Bellinger D, Robins J, Msamanga GI, Manji K, Tronick E. The timing of mother-to-child transmission of human immunodeficiency virus infection and the neurodevelopment of children in Tanzania. Pediatr Infect Dis J. 2006;25(1):47–52. http://journals.lww.com/pidj/Fulltext/2006/01000/The_Timing_of_Mother_to_Child_Transmission_of.12.aspx
  48. 48.
    Msellati P, Lepage P, Hitimana D-G, Van Goethem C, Van de Perre P, Dabis F. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics. 1993;92(6):843–8. Am Acad Pediatrics.PubMedGoogle Scholar
  49. 49.
    Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg. 2001;64(1–2 Suppl):57–67.PubMedGoogle Scholar
  50. 50.
    Nankabirwa J, Wandera B, Kiwanuka N, Staedke SG, Kamya MR, Brooker SJ. Asymptomatic plasmodium infection and cognition among primary schoolchildren in a high malaria transmission setting in Uganda. Am J Trop Med Hyg. 2013;88(6):1102–8. doi: 10.4269/ajtmh. 12-0633.CrossRefPubMedCentralPubMedGoogle Scholar
  51. 51.
    Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, Brooker SJ, Staedke SG, Kamya MR. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis. 2014;58(10):1404–12. Oxford University Press, ciu150.CrossRefPubMedCentralPubMedGoogle Scholar
  52. 52.
    Olney DK, Pollitt E, Kariger PK, Khalfan SS, Ali NS, Tielsch JM, Sazawal S, et al. Young Zanzibari children with iron deficiency, iron deficiency anemia, stunting, or malaria have lower motor activity scores and spend less time in locomotion. J Nutr. 2007;137(12):2756–62.PubMedGoogle Scholar
  53. 53.
    Opoka RO, Bangirana P, Boivin MJ, John CC, Byarugaba J. Seizure activity and neurological sequelae in Ugandan children who have survived an episode of cerebral malaria. Afr Health Sci. 2009;9(2):75–81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19652740
  54. 54.
    Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, Rosenthal PJ, et al. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis. 2012. cir1037 [pii] doi: 10.1093/cid/cir1037. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22308272
  55. 55.
    Thuilliez J, Sissoko MS, Toure OB, Kamate P, Berthélemy JC, Doumbo OK. Malaria and primary education in Mali: a longitudinal study in the village of Donéguébougou. Soc Sci Med. 2010;71(2):324–34. doi: 10.1016/j.socscimed.2010.02.027.
  56. 56.
    Van Rie A, Mupuala A, Dow A. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, democratic Republic of the Congo. Pediatrics. 2008;122(1):e123.CrossRefPubMedCentralPubMedGoogle Scholar
  57. 57.
    Van Rie A, Dow A, Mupuala A, Stewart P. Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, democratic republic of Congo. J Acquir Immune Defic Syndr. 2009;52(5):636–42. doi: 10.1097/QAI.0b013e3181b32646. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19730268
  58. 58.
    White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu Oa, Dondorp AM. Malaria. Lancet. 2014. 383(9918):723–35. doi: 10.1016/S0140-6736(13)60024-0. http://www.ncbi.nlm.nih.gov/pubmed/23953767

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of PsychiatryMakerere University College of Health SciencesKampalaUganda

Personalised recommendations